# Ciitizen Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ciitizen

- Industry: Healthcare IT
- Headquarters: Palo Alto, US
- Website: www.ciitizen.com
- Total disclosed funding: $20M
- Latest round: Series A (Jan 16, 2019)
- Investors on record: 3

## About

Ciitizen Corporation is a healthcare technology company focused on empowering patients to manage and share their medical records effectively, particularly for those with rare diseases.Founded in 2017 in Palo Alto, US, Ciitizen Corporation offers a platform that allows patients to organize their health data into a centralized repository. The company has not undergone any notable changes in business strategy. The founders, Farid Vij and Nasha Fitter, aim to help individuals with rare diseases navigate their medical histories. Ciitizen has secured a total funding of USD 325 mn through multiple rounds, culminating in a TRADE SALE in September 2021, when Invitae Corporation acquired it.Ciitizen Corporation provides Citizen Health, a platform dedicated to managing and sharing medical records for patients, families, and caregivers, particularly in the context of rare diseases. The platform allows users to compile health data from various clinicians and hospitals, enhancing patient engagement and facilitating better healthcare experiences for families and healthcare providers. The service is especially valuable in North America and Europe, where rare diseases have a significant impact.Ciitizen Corporation's revenue model is based on subscription services that grant clients access to their patient data management platform. Clients, primarily patients or families managing rare diseases, subscribe to different service tiers that offer varying features for managing and sharing medical records. This subscription model not only improves user experience but also fosters partnerships with research organizations that utilize anonymized health data for clinical trials and studies. The transactions are primarily direct-to-consumer, ensuring patients' medical histories are accessible for research and healthcare management.With the acquisition by Invitae Corporation in September 2021 for USD 325 mn, Ciitizen Corporation aims to enhance personal health outcomes and support global research initiatives. The company plans to expand its services and reach into new geographic regions, leveraging Invitae's resources to further develop its platform and integrate it with broader healthcare solutions.

## Funding rounds

- Series A, Jan 16, 2019, $17M — Andreessen Horowitz, Section 32, Verily Life Sciences LLC
- Seed, Jul 25, 2018, $3M — Andreessen Horowitz

## Investors

- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed, Series A
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series A
- Verily Life Sciences LLC — Series A